- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced Breast Cancer
Total 14250 results
-
Neovii BiotechTerminatedAdvanced Breast Cancer | Metastatic Breast CancerSpain, Austria, France, Germany, Italy
-
Tata Medical CenterCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast CancerIndia
-
PfizerCompletedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
Hebei Medical University Fourth HospitalRecruitingAdvanced Breast Cancer | HER2-positive Breast CancerChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMelanoma | Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma | Breast Inflammatory CarcinomaUnited States
-
Mayo ClinicRecruitingMetastatic Renal Cell Carcinoma | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 and other conditionsUnited States
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingLocally Advanced Unresectable or Metastatic Solid TumorsChina
-
Suzhou Junjing BioSciences Co., Ltd.Sponsor GmbHNot yet recruitingLocally Advanced or Metastatic Malignant Solid TumorsChina
-
NeuPharma, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, China, Spain, Japan, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
Turning Point Therapeutics, Inc.WithdrawnMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Spain
-
Hanmi Pharmaceutical Company LimitedActive, not recruitingMetastatic Solid Tumor | Locally Advanced Solid TumorKorea, Republic of
-
The Netherlands Cancer InstituteCompletedLocally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast CarcinomaNetherlands
-
Novartis PharmaceuticalsCompletedAdvanced Breast Cancer, Advanced Carcinomas With Squamous Cell HistologyChina
-
Institut du Cancer de Montpellier - Val d'AurelleRecruitingLocally Advanced Pancreatic AdenocarcinomaFrance
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Sun Pharma Advanced Research Company LimitedTerminatedAdvanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States, India
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2/Neu-positive Breast CancerUnited States
-
Spago Nanomedical ABRecruitingSolid Tumor | Metastatic Cancer | Refractory Cancer | Locally Advanced Solid Tumor | Unresectable Solid Tumor | Recurrent Solid TumorAustralia
-
Guangdong Provincial People's HospitalSun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Shantou...RecruitingAdvanced Breast Cancer | HER2-negative Breast CancerChina
-
Fudan UniversityRecruitingBreast Cancer | Advanced Breast CancerChina
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Novartis PharmaceuticalsRecruiting
-
Genor Biopharma Co., Ltd.RecruitingAdvanced Breast CancerChina
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
Fujian Medical University Union HospitalNot yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Breast Cancer
-
European Institute of OncologyRecruiting
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingAdvanced Breast CancerUnited Kingdom
-
Spanish Breast Cancer Research GroupNovartis Pharmaceuticals; ETOP IBCSG Partners Foundation; Breast International...Active, not recruitingAdvanced Breast CancerSpain, Netherlands, France, Italy, Austria, Switzerland
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsActive, not recruiting
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Completed
-
University of Milano BicoccaActive, not recruiting
-
Spanish Breast Cancer Research GroupMerck Sharp & Dohme LLCCompletedTrial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC (PANGEA)Advanced Breast CancerSpain
-
PfizerActive, not recruitingAdvanced Breast CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast CancerAdvanced Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Breast Cancer
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Genzyme, a Sanofi CompanyCompletedAdvanced Breast CancerSouth Africa, Sweden, Hungary, Taiwan, Spain
-
AstraZenecaCompleted
-
Fresenius Kabi Oncology Ltd.Unknown
-
Academy Military Medical Science, ChinaCancer Institute and Hospital, Chinese Academy of Medical SciencesUnknown
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
Centre Jean PerrinGroupement Inter-Régional de Recherche Clinique et d'Innovation Auvergne...RecruitingLocally Advanced Head and Neck CarcinomaFrance
-
BioSyngen Pte LtdShenzhen Second People's HospitalNot yet recruitingLocally Advanced/Metastatic Liver CancerChina
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerGermany